期刊文献+

糖尿病伴或不伴高血压患者CA-199水平相关探讨 被引量:5

Study on the level of CA-199 and correlated factors in diabetic patients with or without hypertension
暂未订购
导出
摘要 目的探讨糖尿病群体各肿瘤指标水平与健康人群之间的差异及相关影响因素。方法 200例2型糖尿病患者,66例性别、年龄匹配的健康对照者行甲胎蛋白(AFP)、癌胚抗原(CEA)和糖链抗原-199(CA-199)测定,同时测定身高和体质量及血糖、血清总胆固醇、三酰甘油、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇和血尿酸。结果糖尿病患者的血清CA-199水平显著高于对照组(P<0.05),>60岁的患者尤为显著(P<0.01),糖尿病伴有高血压的患者血清CA-199水平要高于糖尿病不伴有高血压的患者(P<0.05),糖尿病患者空腹血糖水平与CA-199水平呈正相关(r=0.220,P<0.05);糖尿病患者血清AFP和CEA水平与对照组相比未见明显差异(P>0.05)。结论糖尿病患者(尤其年龄较大的糖尿病患者)血清CA-199水平显著高于健康人群,糖尿病伴高血压患者血清CA-199水平要高于糖尿病不伴高血压患者,提示高血压可能影响糖尿病患者的血清CA-199水平,糖尿病患者空腹血糖水平直接影响CA-199水平。 Objective To compare the differences in the levels of the tumor related index between the diabetic patients and control group and to learn the related factors. Methods 200 patients with type 2 diabetes mellitus and 66 normal controls matched with gender and age had been investigated. The levels of AFP, CEA and CA-199 were determined. The plasma glucose, total cholesterol, triglyceride, HDL-C, LDL-C and uric acid were measured simultaneously. The body height and weight were also recorded. Results Serum level of CA-199 in the diabetic patients was significantly higher than that in the control group(P0.05). Particularly, in the patients aged over 60 years old, the difference were remarkable(P0.01).The level of CA-199 in diabetic patients with hypertension was higher than that in patients without hypertension (P0.05).Moreover, fasting plasma glucose was positively correlated with serum CA-199 levels in diabetic patients(r=0.220,P0.05). There were no significant differences in the levels of serum AFP and CEA between diabetic patients and the control group. Conclusions Serum CA-199 level in diabetic group is higher than that in control group, especially in the people who are aged over 60 years old. Also, diabetic patients with hypertension show difference from those without hypertension in serum levels of CA-199. Fasting plasma glucose is correlated with serum CA-199 levels in diabetes patients.
出处 《实用老年医学》 CAS 2012年第6期487-490,共4页 Practical Geriatrics
关键词 糖尿病 高血压 肿瘤指标 diabetes hypertension tumor related index
  • 相关文献

参考文献3

二级参考文献18

  • 1李英梅,夏稻子,马秀丽,刘聪.糖尿病患者胰腺的超声组织定征研究[J].中国医学影像技术,2006,22(3):436-438. 被引量:30
  • 2徐婷,颜勤明,徐丽伟.2型糖尿病患者血清CA19-9浓度的变化及其与血糖的相关性[J].实用医学杂志,2007,23(5):676-677. 被引量:21
  • 3Oya Uygur-Bayramicli,Resat Dabak,Ekrem Orbay,Can Dolapclo■lu,Mehmet Sargin,Gamze Kilico■lu,Yüksel Güleryüzlü,Alpaslan Mayada■li.Type 2 diabetes mellitus and CA 19-9 levels[J].World Journal of Gastroenterology,2007,13(40):5357-5359. 被引量:64
  • 4Lucio Gullo.Diabetes and the Risk of Pancreatic Cancer[J].Annals of Oncology.1999(4)
  • 5Locker GY,Hamilton S,Harris J,Jessup JM,Kemeny N,Macdonald JS,Somerfield MR,Hayes DF,Bast RC Jr.ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer[].Journal of Clinical Oncology.2006
  • 6Murray MD,Burton FR,Di Bisceglie AM.Markedly elevated serum CA 19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis[].Journal of Clinical Gastroenterology.2007
  • 7Mohan V,Premalatha G,and Pitchumoni CS.Pancreatic diseases and diabetes[].Textbook of diabetes.2003
  • 8Gullo L.Diabetes and the risk of pancreatic cancer[].Annals of Oncology.1999
  • 9Banff G,Ardemagni A,Bravi S,Pacchioni M,Bonini P.Are diabetic metabolic compensation and CA19.9 really correlated[].International Journal of Biological Markers.1996
  • 10U.K. Prospective Diabetes Study Group.U.K.Prospective Diabetes Study 16:Overview of 6 years‘ therapy of typeⅡdiabetes:a progressive disease[].Diabetes.1995

共引文献102

同被引文献54

  • 1王智,马晋平,林建伟,陈创奇,蔡世荣,何裕隆.术前中性粒细胞与淋巴细胞比值与结直肠癌患者预后的关系[J].消化肿瘤杂志(电子版),2011,3(4):246-250. 被引量:17
  • 2李英梅,夏稻子,马秀丽,刘聪.糖尿病患者胰腺的超声组织定征研究[J].中国医学影像技术,2006,22(3):436-438. 被引量:30
  • 3Oya Uygur-Bayramicli,Resat Dabak,Ekrem Orbay,Can Dolapclo■lu,Mehmet Sargin,Gamze Kilico■lu,Yüksel Güleryüzlü,Alpaslan Mayada■li.Type 2 diabetes mellitus and CA 19-9 levels[J].World Journal of Gastroenterology,2007,13(40):5357-5359. 被引量:64
  • 4赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
  • 5Renehan A,Smith U,Kirkman MS. Linking diabetes and can- cer :a consensus on complexity [J]. Lancet,2010,375 (9733) : 2201-2220.
  • 6Muniraj T,Chari ST. Diabetes and pancreatic cancer [J]. Minerva Gastroenterol Dietol, 2012,58 (4) : 331-345.
  • 7Wideroff L,Gridley G,Mellemkjaer L,et al. Cancer inci- dence in a population- based cohort of Patients hospital- ized with diabetes mellitus in Denmark [J]. J Natl Cancer Inst, 1997, 89(18) : 1360-1365.
  • 8Adami HO,Chow WH,Nyen O,et al. Excess risk of Prima- ry liver cancer in Patients With diabetes mellitus [J]. J Natl Cancer Inst, 1996,88 (20) : 1472-1477.
  • 9Yang YX, Hemessy S, Lewis JD. Type2 diabetes mellitus and the risk of colirectal cancer [ J]. Clin Gastmenterol Hepalol, 2005, 3 ( 6 ) : 587 - 594.
  • 10Renehan A, Smith U, Kirkman MS. Linking diabetes and cancer: a consensus on complexity [ J ]. Lancet, 2010, 375 (9733) : 2201 - 2202.

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部